Compare TAL & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TAL | BLCO |
|---|---|---|
| Founded | 2003 | 1853 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Ophthalmic Goods |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 6.0B |
| IPO Year | 2010 | 2022 |
| Metric | TAL | BLCO |
|---|---|---|
| Price | $11.11 | $16.94 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 14 |
| Target Price | $12.66 | ★ $17.31 |
| AVG Volume (30 Days) | ★ 2.7M | 338.6K |
| Earning Date | 01-29-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 136.94 | N/A |
| EPS | ★ 0.28 | N/A |
| Revenue | $2,653,037,000.00 | ★ $4,976,000,000.00 |
| Revenue This Year | $35.72 | $8.06 |
| Revenue Next Year | $24.33 | $5.79 |
| P/E Ratio | $39.81 | ★ N/A |
| Revenue Growth | ★ 44.45 | 6.23 |
| 52 Week Low | $8.50 | $10.45 |
| 52 Week High | $15.30 | $18.14 |
| Indicator | TAL | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 47.96 | 49.10 |
| Support Level | $10.64 | $16.85 |
| Resistance Level | $11.40 | $17.54 |
| Average True Range (ATR) | 0.42 | 0.43 |
| MACD | -0.05 | -0.06 |
| Stochastic Oscillator | 25.56 | 47.56 |
TAL Education Group is a smart learning solutions provider in China. It operates a few business lines including enrichment learning, high school academic tutoring, learning technology, and content solutions. Among those business lines, TAL focuses on enrichment learning and content solutions.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.